New Ray Medicine International Holding Limited

HK$0.34As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6108Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (24.38%)
Div yield —
ROE (3.76%)
Pharmaceutical Retailers
Beta (5Y) (4.08)
PE TTM —
TSR TTM (1.43%)
Mkt cap HK$69.21M
ROIC (3.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.40
15.82%
(57.28%)
Hold 10|12|6|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
19.02%
26.90%
26.90%
28.66%
Revenue$M
5.494
5.409
5.657
5.904
(6.60%)
(5.65%)
1.63%
4.80%
Peers (US$8.829M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.159
0.580
0.420
EBIT/Intx
0.504
0.216
0.214
Own earn%
63.08
14.40
36.48
Sh yield%
42.89
45.71
42.60
Owners
Insiders/Inst%
1.88
75.71
Short interest%
1.09
SBC / revenue%
1.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
18–21
$1 testx
—
Incr. ROIC%
9